Sie suchten nach: ċitoġenetiċi (Maltesisch - Englisch)

anormalitajiet ċitoġenetiċi
cytogenetic abnormalities

2kriterji għar-risponsijiet ċitoġenetiċi:
2 cytogenetic response criteria:

Ċitoġenetiċi wara terapija b’trisenox
cytogenetics after trisenox therapy

Ċitoġenetiċi konvenzjonali [t(15;17)]
conventional cytogenetics [t(15;17)]

tliet pazjenti kellhom anormalitajiet ċitoġenetiċi fil-linja bażi.
three patients had cytogenetic abnormalities at baseline.

hu magħruf li anormalitajiet ċitoġenetiċi jseħħu f’pazjenti b’saa.
cytogenetic abnormalities are known to occur in saa patients.

abnormalitajiet ċitoġenetiċi kienu evalwati f’117 mill-popolazzjoni kollha ta’
cytogenetic abnormalities were evaluated in 117 of the total population of 176patients.

jekk jidhru anormalitajiet ċitoġenetiċi ġodda, wieħed irid iqis jekk jixraqx li jitwaqqaf eltrombopag.
if new cytogenetic abnormalities are detected, it must be evaluated whether continuation of eltrombopag is appropriate.

anormalitajiet ċitoġenetiċi kienu evalwati f’117 mill-popolazzjoni kollha ta’ 176 pazjent.
cytogenetic abnormalities were evaluated in 117 of the total population of 176 patients.

anormalitajiet ċitoġenetiċi kienu evalwati f’117, mill- popolazzjoni totali ta’ 176 pazjent.
cytogenetic abnormalities were evaluated in 117 of the total population of 176 patients.

slamf7 tinstab fi kwantità għolja f’ċelloli tal-majeloma multipla indipendentement minn anormalitajiet ċitoġenetiċi.
slamf7 is highly expressed on multiple myeloma cells independent of cytogenetic abnormalities.

ir-risponsi ematoloġiċi u ċitoġenetiċi ġew evalwati mill-investigatur u mill-irc b’riżultati simili.
haematologic and cytogenetic responses were assessed by the investigator and by the irc with similar results.

anormalitajiet ċitoġenetiċi transitorji ġew osservati f’donaturi b’saħħithom wara l-użu ta’ g-csf.
transient cytogenetic abnormalities have been observed in normal donors following g-csf use.

jekk ikun hemm anormalitajiet ċitoġenetiċi ġodda, wieħed għandu jqis jekk jixraqx li tieqaf tieħu eltrombopag (ara sezzjonijiet 4.4 u 4.8).
if new cytogenetic abnormalities are detected, it must be evaluated whether continuation of eltrombopag is appropriate (see sections 4.4 and 4.8).

analiżi fish (>/= 200 ċelloli) tista' tintuża għal evalwazzjonijiet ċitoġenetiċi wara l-linja bażi jekk ma jkunx hemm>/= 20 metafażi disponibbli.
fish analysis (>/= 200 cells) could be used for post-baseline cytogenetic assessments if >/= 20 metaphases were not available.

subset ta’ madwar 12 % tal-pazjenti li fil-bidu kellhom parametri ċitoġenetiċi normali, sussegwentement instabu li kellhom abnormalitajiet, fosthom monosomy 7, f’analiżi li ġew ripetuti perjodikament.
a subset of approximately 12% of patients who had normal cytogenetic evaluations at baseline were subsequently found to have abnormalities, including monosomy 7, on routine repeat evaluation.